Overview

Registry For Patients Treated With BeneFix In Usual Care Setting In Germany

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this observational study is to describe the incidence of adverse events among patients treated with BeneFix® in usual health care settings in Germany.
Details
Lead Sponsor:
Pfizer